Title : Brivanib in combination with Notch3 silencing shows potent activity in tumour models.

Pub. Date : 2019 Mar

PMID : 30765875






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The therapeutic potential of Notch3 inhibition combined with brivanib treatment was also demonstrated in a rat model of HCC and in cell lines derived from different human cancers. brivanib HCC Homo sapiens
2 CONCLUSION: We have demonstrated that regulation of the TCA cycle is a common mechanism in different human cancers, suggesting that Notch3 inhibitors combined with brivanib treatment may represent a strong formulation for the treatment of HCC as well as Notch3-driven cancers. brivanib HCC Homo sapiens